Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
G1 Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
G1 Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
G1 Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
G1 Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
G1 Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
G1 Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 12
Venture Financing 12
G1 Therapeutics Raises USD47 Million in Series C Financing 12
G1 Therapeutics Raises USD33 Million in Series B Financing 14
G1 Therapeutics Raises US$12.5 Million In Series A Financing 16
G-Zero Therapeutics Raises US$1.3 Million In Venture Financing 17
G1 Therapeutics Raises US$0.6 Million In Seed Financing 18
G1 Therapeutics Raises US$0.8 Million In Venture Financing 19
Partnerships 20
GeneCentric Therapeutics Enters into Research Partnership with G1 Therapeutics 20
G1 Therapeutics Enters into Collaboration Agreement with AstraZeneca 21
G1 Therapeutics Enters into Agreement with Genentech 22
Licensing Agreements 23
G1 Therapeutics Amends Licensing Agreement With Board Of Trustees Of The University Of Illinois 23
Equity Offering 24
G1 Therapeutics Raises USD207 Million in Public Offering of Shares 24
G1 Therapeutics Raises USD115.3 Million in Public Offering of Shares 26
G1 Therapeutics Raises USD116.7 Million in IPO 28
G1 Therapeutics Inc – Key Competitors 30
G1 Therapeutics Inc – Key Employees 31
G1 Therapeutics Inc – Locations And Subsidiaries 32
Head Office 32
Recent Developments 33
Financial Announcements 33
Aug 08, 2018: G1 Therapeutics provides second quarter 2018 corporate and financial update 33
May 03, 2018: G1 Therapeutics Provides First Quarter 2018 Corporate and Financial Update 35
Feb 21, 2018: G1 Therapeutics Reports Fourth Quarter and Full-Year 2017 Financial Results 36
Nov 08, 2017: G1 Therapeutics Reports Third Quarter 2017 Financial Results and Recent Operational Highlights 38
Aug 09, 2017: G1 Therapeutics Reports Second Quarter 2017 Financial Results and Recent Operational Highlights 39
Corporate Communications 41
Jul 09, 2018: G1 Therapeutics Appoints John Demaree As Chief Commercial Officer And Stillman Hanson As General Counsel 41
Jun 08, 2018: G1 Therapeutics Announces Appointment of New Members to the Board of Directors 42
Dec 18, 2017: G1 Therapeutics Added to Nasdaq Biotechnology Index 43
Sep 18, 2017: G1 Therapeutics Added to Russell 2000, 3000 and Microcap Indexes 44
Jul 13, 2017: G1 Therapeutics Appoints Sir Andrew Witty to Board of Directors 45
Product News 46
06/02/2018: G1 Therapeutics Presents Phase 1b Data on G1T38 in Combination with Faslodex for Treatment of Breast Cancer at 2018 American Society of Clinical Oncology (ASCO) Annual Meeting 46
05/16/2018: G1 Therapeutics to Present Phase 1b Data on G1T38 in Combination with Faslodex for Treatment of Breast Cancer at 2018 American Society of Clinical Oncology Annual Meeting 48
04/16/2018: G1 Therapeutics Announces Initiation of Phase 1b/2 Clinical Trial of G1T38 in Combination with Tagrisso for EGFR-Mutant Non-Small Cell Lung Cancer 49
01/10/2017: G1 Therapeutics Initiates Phase 1b/2a Trial of G1T38 in Estrogen Receptor-Positive Breast Cancer 50
Clinical Trials 51
Apr 09, 2018: G1 Therapeutics to Present Preclinical Data on G1T38 at the 2018 American Association for Cancer Research (AACR) Annual Meeting 51
Mar 29, 2017: G1 Therapeutics Announces Presentation on G1T38 at the 2017 American Association for Cancer Research Annual Meeting 52
Mar 29, 2017: G1 Therapeutics Announces Presentation on G1T48 at the 2017 American Association for Cancer Research Annual Meeting 53
Jan 10, 2017: G1 Therapeutics Initiates Phase 2 trial of Trilaciclib in Triple-Negative Breast Cancer 54
Jan 10, 2017: G1 Therapeutics to Start Phase I Study of G1T48 in Q4 2017 55
Appendix 56
Methodology 56
About GlobalData 56
Contact Us 56
Disclaimer 56
G1 Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
G1 Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
G1 Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
G1 Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
G1 Therapeutics Inc, Deals By Therapy Area, 2012 to YTD 2018 9
G1 Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
G1 Therapeutics Raises USD47 Million in Series C Financing 12
G1 Therapeutics Raises USD33 Million in Series B Financing 14
G1 Therapeutics Raises US$12.5 Million In Series A Financing 16
G-Zero Therapeutics Raises US$1.3 Million In Venture Financing 17
G1 Therapeutics Raises US$0.6 Million In Seed Financing 18
G1 Therapeutics Raises US$0.8 Million In Venture Financing 19
GeneCentric Therapeutics Enters into Research Partnership with G1 Therapeutics 20
G1 Therapeutics Enters into Collaboration Agreement with AstraZeneca 21
G1 Therapeutics Enters into Agreement with Genentech 22
G1 Therapeutics Amends Licensing Agreement With Board Of Trustees Of The University Of Illinois 23
G1 Therapeutics Raises USD207 Million in Public Offering of Shares 24
G1 Therapeutics Raises USD115.3 Million in Public Offering of Shares 26
G1 Therapeutics Raises USD116.7 Million in IPO 28
G1 Therapeutics Inc, Key Competitors 30
G1 Therapeutics Inc, Key Employees 31
List of Figures
G1 Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
G1 Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
G1 Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
G1 Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
G1 Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
G1 Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
G1 Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
G1 Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9